Results 141 to 150 of about 260,092 (192)

Tuberculosis infection control in MDR-TB designated hospitals in Jiangsu Province, China. [PDF]

J Clin Tuberc Other Mycobact Dis
Song H, Li G, Xu Z, Wang F, Wang X, Dai B, Zhang X, Li J, Li Y, Zhu L.   +9 more
europepmc   +1 more source

Wild-type MIC distribution and evaluation of epidemiological cut-offs of second-line TB-drugs in susceptible and MDR-TB clinical isolates from Chennai, India. [PDF]

Front Microbiol
Dusthackeer A, Balasubramanian M, Rajadas SE, Nirmal CR, Elango P, Thiruvengadam K, Saadhali SA, Shanmugam S.   +7 more
europepmc   +1 more source

Factors Affecting Treatment Adherence Among Persons With Multidrug-Resistant Tuberculosis (MDR-TB) in Western India: A Qualitative Exploration. [PDF]

Cureus
Ladha N, Kikkeri Hanumantha Setty N, Bhardwaj P.   +2 more
europepmc   +1 more source

Pyrazinamide susceptibility testing in <i>Mycobacterium tuberculosis</i>: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate diagnosis in a low-MDR-TB-incidence context. [PDF]

Front Cell Infect Microbiol
Semenova T, Gonzalez G, Lechartier B, Sander P, von Garnier C, Schulthess B, Mazza-Stalder J, Greub G, Opota O.   +8 more
europepmc   +1 more source

Burden and determinants of MDR-TB among prisoners in sub-Saharan Africa: Systematic review and meta-analysis protocol. [PDF]

J Public Health Afr
Sakala DY, Tamuzi JM, Shumba CS, Nyasulu PS.   +3 more
europepmc   +1 more source

A new multiplex molecular assay based on padlock probes and rolling circle amplification for MDR-TB detection in clinical specimens: a prospective diagnostic accuracy study. [PDF]

Ther Adv Infect Dis
Dudnyk A, Tytarenko N, Lytvyniuk O, Tolstova O, Millet JP, Molina I, Antuori A, Ciobanu N, Crudu V, Domínguez J.   +9 more
europepmc   +1 more source

Global, regional, and national burdens of MDR-TB attributable to smoking from 1990 to 2021 with a prediction from 2022 to 2050. [PDF]

Front Public Health
Dan D, Lei Z, Xue W, Ze-Xin L.
europepmc   +1 more source

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis. [PDF]

Pathogens
Bogiel T, Dolska E, Zimna M, Nakonowska K, Krawiecka D, Żebracka R, Pochowski M, Krawczyk A.   +7 more
europepmc   +1 more source

Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB. [PDF]

J Clin Microbiol
Hoffmann H, Golubov A, Corbett C, Allamuratova D, Antonenka U, Heiß-Neumann M, Hofmann-Thiel S, Sharma K, Turaev L, Sinitski D, Kabirov O.   +10 more
europepmc   +1 more source